Literature DB >> 8213976

Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis.

M I Roat1, M Ohji, L E Hunt, R A Thoft.   

Abstract

Atopic diseases that include eczema (atopic dermatitis), asthma, and seasonal and perennial rhinoconjunctivitis are common manifestations of abnormal immediate hypersensitivity. Ocular involvement, such as atopic keratoconjunctivitis, characteristically includes conjunctival and corneal inflammation, and in a severe form, conjunctival scarring, symblepharon, corneal epitheliopathy, and visual loss. To examine the conjunctival cellular abnormalities in atopic keratoconjunctivitis, we studied the in vivo differentiation and tissue-culture growth characteristics of conjunctiva from normal subjects and patients with severe atopic keratoconjunctivitis. We examined conjunctival biopsy specimens to determine epithelial mitotic rate and goblet cell frequency, and we studied conjunctival explants to determine the latent period for fibroblast outgrowth and fibroblast doubling time. The mitotic rate for atopic keratoconjunctivitis, 6.7% +/- 2.1% (11 patients), was statistically significantly greater than for normal subjects, 2.0% +/- 0.63% (seven subjects) (P = .05). Also the goblet cell frequency for atopic keratoconjunctivitis, 14.6% +/- 3.4% (11 patients), was statistically significantly greater than for normal subjects, 4.8% +/- 0.92% (seven subjects) (P = .02). The latent period for fibroblast outgrowth and the fibroblast doubling time for atopic keratoconjunctivitis were not statistically significantly different from normal control subjects. Therefore, atopic keratoconjunctivitis was associated with conjunctival epithelial hypermitosis, goblet cell hyperplasia, and normal fibroblast tissue-culture growth. These characteristics may be useful in the diagnosis of atopic keratoconjunctivitis. We previously studied another disease characterized by chronic conjunctival inflammation and scarring, cicatricial pemphigoid, which also demonstrated conjunctival epithelial hypermitosis, but in contrast there was near absence of goblet cells, and the fibroblasts were hyperproliferative. These differences may be used to distinguish atopic keratoconjunctivitis from cicatricial pemphigoid.

Entities:  

Mesh:

Year:  1993        PMID: 8213976     DOI: 10.1016/s0002-9394(14)71404-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Authors:  C S De Paiva; J K Raince; A J McClellan; K P Shanmugam; S B Pangelinan; E A Volpe; R M Corrales; W J Farley; D B Corry; D-Q Li; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-12-22       Impact factor: 7.313

2.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

Authors:  Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2013-08-14       Impact factor: 3.467

Review 3.  Conjunctival mucoepithelial hyperplasia of the elderly.

Authors:  Akiko Ohashi; Ahmed Ali Elsayed; Tetsushi Yasuma; Takahiko Iijima; Shigeo Nakamura
Journal:  Int Ophthalmol       Date:  2015-05-16       Impact factor: 2.031

4.  IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells.

Authors:  Johanna Tukler Henriksson; Terry G Coursey; David B Corry; Cintia S De Paiva; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

5.  Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion.

Authors:  Densen Hayashi; Dayu Li; Chisato Hayashi; Marie Shatos; Robin R Hodges; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

6.  Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.

Authors:  Jian Gu; Lili Chen; Marie A Shatos; J David Rios; Abha Gulati; Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2007-11-17       Impact factor: 3.467

Review 7.  [Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

Authors:  A Wollenberg; K Kerschenlohr; T Pavicic; E M Messmer
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

Review 8.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

9.  Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis.

Authors:  K Yokoi; N Yokoi; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

Review 10.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.